Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

More Consistency Needed in Application of Harm Reduction Principles in Australia
  • USA - English


News provided by

Frost & Sullivan

10 Mar, 2020, 12:32 IST

Share this article

Share toX

Share this article

Share toX

Although smoke-free nicotine products are encouraged by public health bodies in other countries as a tobacco harm reduction measure, they remain largely illegal in Australia, finds Frost & Sullivan

SYDNEY, March 10, 2020 /PRNewswire/ -- The lack of harm reduction principles for tobacco use in Australia is inconsistent with their implementation in many other areas of public policy. Alcohol restrictions, needle exchange programmes, legalisation of medicinal cannabis, free condom programmes, and even mandatory bike helmets are just some of the harm reduction measures that have been introduced by the Commonwealth and State/Territory governments in recent years. Although the use of harm reduction principles for illegal drugs has been a key part of national policy since the 1980s, they have not been applied to tobacco.

Frost & Sullivan's latest thought leadership white paper, Harm Reduction in an Australian Context, highlights the history of harm reduction and its application across various behaviours and products, including tobacco. The use of harm reduction principles in public health policy in Australia is also discussed, along with the current status of tobacco harm reduction policies. 

To download the complimentary white paper, please visit: http://frost.ly/40v

"Smoke-free nicotine products (SFNPs) can potentially have a significant impact in areas where smoking rates are relatively high and there is a lack of resources to support existing smokers, such as the Northern Territory," explained Mark Dougan, Director at Frost & Sullivan. "Under current law, only tobacco in its most harmful form—combustible cigarettes—is legally available in Australia, while less-harmful, smoke-free alternatives such as e-cigarettes and heated tobacco are generally prohibited."

This also sets Australia apart from most other developed countries, such as the UK, Canada and the US, where harm reduction principles are being applied in tobacco control policies and SFNPs are seen as an effective tool in reducing harm from tobacco use.

Research conducted by Frost & Sullivan in 2019 found a majority of healthcare professionals in Australia want to see SFNPs, such as e-cigarettes and heated tobacco products, legalised and regulated appropriately in Australia. The survey revealed that nearly 60% of healthcare professionals agreed that these products should be legalised, provided they are strongly regulated to ensure there is no uptake among youth and non-smokers.

Harm reduction principles are being increasingly applied to tobacco use globally, particularly through the regulated use of SFNPs, which:

  • Deliver tobacco and/or nicotine to users in a way that avoids tobacco combustion
  • Avoid much of the harmful chemicals in tobacco smoke
  • Reduce the harm from tobacco/nicotine consumption for smokers who are unable or unwilling to quit

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Melissa Tan
Corporate Communications, Frost & Sullivan
E: [email protected]
P: +65 68900926

http://ww2.frost.com

Related Links

https://ww2.frost.com/

Modal title

Also from this source

CtrlS Datacenters Receives Frost & Sullivan's 2025 India Competitive Strategy Leadership Recognition in Data Center Services

CtrlS Datacenters Receives Frost & Sullivan's 2025 India Competitive Strategy Leadership Recognition in Data Center Services

Frost & Sullivan is pleased to announce that CtrlS Datacenters (CtrlS) has been conferred the 2025 India Competitive Strategy Leadership Recognition...

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Tobacco

Tobacco

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.